Two additional US Patents issued for Single Cell Technology

Single Cell Technology is proud to announce two new US patents issued, shoring up its intellectual property portfolio. US Patent No. 9,944,983, titled "Method of screening a plurality of single secreting cells for functional activity" was issued on Apr. 17, 2018 and US patent no. 9,873,871 titled "Method of obtaining antibodies of interest and nucleotides encoding same" was issued on Jan. 23, 2018. The issuance of these patents brings the number of patents issued in the US to 5 and worldwide to 10.

"These patents cover SCT's core methodology specifically tailored to discovering antibodies and also an important application for functional testing of antibodies," said Dr. Chun-Nan Chen, CEO and CSO. "These patents show the world that we really have tapped into a rich and useful technology that has wide reaching applications and advantages," he added.